- Home
- VALU vs HUMA Comparison
VALU vs HUMA Comparison
Compare VALU & HUMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VALU
- HUMA
- Stock Information
- Founded
- VALU 1931
- HUMA 2004
- Country
- VALU United States
- HUMA United States
- Employees
- VALU N/A
- HUMA N/A
- Industry
- VALU Investment Managers
- HUMA Biotechnology: Pharmaceutical Preparations
- Sector
- VALU Finance
- HUMA Health Care
- Exchange
- VALU Nasdaq
- HUMA Nasdaq
- Market Cap
- VALU 370.2M
- HUMA 427.2M
- IPO Year
- VALU N/A
- HUMA N/A
- Fundamental
- Price
- VALU $40.44
- HUMA $1.37
- Analyst Decision
- VALU
- HUMA Strong Buy
- Analyst Count
- VALU 0
- HUMA 6
- Target Price
- VALU N/A
- HUMA $14.60
- AVG Volume (30 Days)
- VALU 10.4K
- HUMA 6.8M
- Earning Date
- VALU 03-14-2025
- HUMA 05-09-2025
- Dividend Yield
- VALU 3.01%
- HUMA N/A
- EPS Growth
- VALU 17.96
- HUMA N/A
- EPS
- VALU 2.28
- HUMA N/A
- Revenue
- VALU $35,695,000.00
- HUMA N/A
- Revenue This Year
- VALU N/A
- HUMA N/A
- Revenue Next Year
- VALU N/A
- HUMA $1,178.15
- P/E Ratio
- VALU $17.48
- HUMA N/A
- Revenue Growth
- VALU N/A
- HUMA N/A
- 52 Week Low
- VALU $32.94
- HUMA $1.15
- 52 Week High
- VALU $57.68
- HUMA $9.97
- Technical
- Relative Strength Index (RSI)
- VALU 53.88
- HUMA 33.72
- Support Level
- VALU $38.04
- HUMA $1.43
- Resistance Level
- VALU $41.85
- HUMA $1.70
- Average True Range (ATR)
- VALU 1.75
- HUMA 0.16
- MACD
- VALU 0.20
- HUMA 0.06
- Stochastic Oscillator
- VALU 77.37
- HUMA 50.00
About VALU Value Line Inc.
Value Line Inc is a U.S based company. It produces investment periodicals based on underlying research and making available copyright data, including ranking system and other information, to third parties under written agreements for use in third-party managed and marketed investment products and for other purposes. The company markets under brands including Value Line, the Value Line logo, The Value Line Investment Survey, Smart Research, Smarter Investing and a trusted name in Investment Research. Its only operating segment being Publishing.
About HUMA Humacyte Inc.
Humacyte Inc is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions.